Concepts (240)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Health Resources | 3 | 2019 | 920 | 0.880 |
Why?
|
Public Facilities | 1 | 2020 | 34 | 0.740 |
Why?
|
Infant Mortality | 3 | 2017 | 749 | 0.660 |
Why?
|
Hospitals, Public | 1 | 2020 | 204 | 0.660 |
Why?
|
Education, Public Health Professional | 1 | 2018 | 24 | 0.660 |
Why?
|
Ethiopia | 6 | 2021 | 490 | 0.640 |
Why?
|
Child Mortality | 3 | 2017 | 191 | 0.630 |
Why?
|
Financing, Organized | 1 | 2019 | 202 | 0.610 |
Why?
|
Time and Motion Studies | 1 | 2017 | 148 | 0.580 |
Why?
|
Delivery of Health Care | 8 | 2018 | 5272 | 0.550 |
Why?
|
Maternal Mortality | 2 | 2016 | 312 | 0.540 |
Why?
|
Health Care Costs | 2 | 2020 | 3226 | 0.530 |
Why?
|
Developing Countries | 9 | 2018 | 2779 | 0.530 |
Why?
|
International Cooperation | 4 | 2018 | 1420 | 0.520 |
Why?
|
Primary Health Care | 5 | 2021 | 4537 | 0.510 |
Why?
|
Financing, Government | 1 | 2018 | 470 | 0.500 |
Why?
|
Health Expenditures | 8 | 2019 | 2348 | 0.480 |
Why?
|
Cost of Illness | 3 | 2020 | 1849 | 0.400 |
Why?
|
Health Services Accessibility | 4 | 2019 | 5128 | 0.360 |
Why?
|
Leadership | 1 | 2018 | 1349 | 0.340 |
Why?
|
Proinsulin | 1 | 2009 | 133 | 0.330 |
Why?
|
Euthyroid Sick Syndromes | 1 | 2008 | 14 | 0.330 |
Why?
|
Health Promotion | 2 | 2017 | 2187 | 0.320 |
Why?
|
Accounting | 2 | 1999 | 24 | 0.320 |
Why?
|
Hypoxanthines | 4 | 1991 | 35 | 0.300 |
Why?
|
Program Evaluation | 1 | 2016 | 2484 | 0.300 |
Why?
|
Mutagenesis, Insertional | 1 | 2009 | 656 | 0.280 |
Why?
|
Health Care Sector | 2 | 2007 | 194 | 0.270 |
Why?
|
Artemisinins | 3 | 1997 | 223 | 0.270 |
Why?
|
Sesquiterpenes | 3 | 1997 | 176 | 0.270 |
Why?
|
Financing, Personal | 1 | 2007 | 310 | 0.250 |
Why?
|
Thyroxine | 1 | 2008 | 666 | 0.250 |
Why?
|
National Health Programs | 2 | 1999 | 445 | 0.240 |
Why?
|
Health Policy | 2 | 2015 | 2655 | 0.230 |
Why?
|
Xanthine Oxidase | 3 | 1991 | 64 | 0.220 |
Why?
|
Public Sector | 5 | 2007 | 266 | 0.220 |
Why?
|
Family Characteristics | 3 | 2017 | 997 | 0.210 |
Why?
|
Financial Support | 3 | 2016 | 115 | 0.200 |
Why?
|
India | 2 | 2019 | 2189 | 0.200 |
Why?
|
Antimalarials | 3 | 1997 | 913 | 0.190 |
Why?
|
Indonesia | 3 | 2017 | 114 | 0.190 |
Why?
|
Healthcare Disparities | 1 | 2016 | 3138 | 0.190 |
Why?
|
Erythrocytes | 4 | 1991 | 2453 | 0.190 |
Why?
|
Economic Development | 2 | 2018 | 69 | 0.190 |
Why?
|
Health Care Reform | 2 | 2007 | 1258 | 0.180 |
Why?
|
Autoantibodies | 1 | 2008 | 2020 | 0.180 |
Why?
|
Body Composition | 1 | 2009 | 2397 | 0.170 |
Why?
|
Public Assistance | 2 | 2017 | 48 | 0.170 |
Why?
|
Family Planning Services | 2 | 2019 | 246 | 0.170 |
Why?
|
Polymorphism, Genetic | 1 | 2009 | 4332 | 0.160 |
Why?
|
Heme | 2 | 1997 | 306 | 0.160 |
Why?
|
Education, Graduate | 1 | 2018 | 81 | 0.160 |
Why?
|
Time Management | 1 | 2017 | 50 | 0.150 |
Why?
|
Hemin | 2 | 1996 | 49 | 0.150 |
Why?
|
Health Services | 2 | 2018 | 757 | 0.150 |
Why?
|
Private Sector | 4 | 2007 | 391 | 0.140 |
Why?
|
Socioeconomic Factors | 6 | 2019 | 7726 | 0.140 |
Why?
|
Prenatal Care | 2 | 2021 | 1087 | 0.140 |
Why?
|
Membrane Lipids | 1 | 1997 | 248 | 0.130 |
Why?
|
Program Development | 2 | 2018 | 1313 | 0.130 |
Why?
|
Dipeptidases | 1 | 2014 | 38 | 0.120 |
Why?
|
State Medicine | 1 | 2015 | 219 | 0.120 |
Why?
|
Lubricants | 1 | 2013 | 31 | 0.120 |
Why?
|
Phosphoribosyl Pyrophosphate | 2 | 1990 | 5 | 0.120 |
Why?
|
Hospital Costs | 1 | 2020 | 982 | 0.120 |
Why?
|
Purines | 3 | 1991 | 593 | 0.110 |
Why?
|
Ambulatory Care | 2 | 2004 | 2711 | 0.110 |
Why?
|
Health Services Needs and Demand | 2 | 2015 | 1409 | 0.110 |
Why?
|
Goals | 1 | 2017 | 702 | 0.100 |
Why?
|
Data Collection | 2 | 1999 | 3341 | 0.100 |
Why?
|
Maternal Health Services | 2 | 2019 | 452 | 0.100 |
Why?
|
Humans | 38 | 2021 | 739398 | 0.100 |
Why?
|
Food Supply | 1 | 2017 | 509 | 0.100 |
Why?
|
Plasmodium falciparum | 2 | 1991 | 1730 | 0.100 |
Why?
|
Glutaryl-CoA Dehydrogenase | 1 | 2010 | 19 | 0.100 |
Why?
|
Pentosephosphates | 1 | 1990 | 6 | 0.100 |
Why?
|
Social Planning | 1 | 2010 | 11 | 0.090 |
Why?
|
South Africa | 3 | 2013 | 1743 | 0.090 |
Why?
|
Privatization | 3 | 2005 | 41 | 0.090 |
Why?
|
Child, Preschool | 10 | 2017 | 40802 | 0.090 |
Why?
|
Organizational Case Studies | 2 | 2007 | 299 | 0.080 |
Why?
|
Social Justice | 2 | 2007 | 456 | 0.080 |
Why?
|
Urban Population | 1 | 2017 | 2014 | 0.080 |
Why?
|
Quality of Health Care | 2 | 2021 | 4365 | 0.080 |
Why?
|
Health Services Research | 3 | 2003 | 1832 | 0.070 |
Why?
|
Infant | 7 | 2017 | 34923 | 0.070 |
Why?
|
Public Health | 2 | 2019 | 2587 | 0.070 |
Why?
|
Hypoxanthine | 3 | 1991 | 28 | 0.070 |
Why?
|
Turkey | 1 | 2007 | 234 | 0.070 |
Why?
|
Rural Population | 1 | 2017 | 2181 | 0.070 |
Why?
|
Child Health Services | 1 | 2012 | 665 | 0.070 |
Why?
|
Cross-Cultural Comparison | 1 | 2010 | 648 | 0.070 |
Why?
|
Obesity | 1 | 2009 | 12643 | 0.070 |
Why?
|
Residence Characteristics | 1 | 2016 | 2041 | 0.070 |
Why?
|
Trace Elements | 1 | 1988 | 198 | 0.070 |
Why?
|
False Positive Reactions | 1 | 2008 | 982 | 0.070 |
Why?
|
Homosexuality, Male | 1 | 2013 | 1239 | 0.070 |
Why?
|
Subcutaneous Fat | 1 | 2009 | 392 | 0.070 |
Why?
|
Boston | 1 | 2018 | 9314 | 0.070 |
Why?
|
Curriculum | 1 | 2018 | 3575 | 0.070 |
Why?
|
Insurance, Health | 2 | 2015 | 2491 | 0.060 |
Why?
|
Phosphates | 1 | 1988 | 785 | 0.060 |
Why?
|
Premenopause | 1 | 2009 | 1028 | 0.060 |
Why?
|
Private Practice | 1 | 2005 | 154 | 0.060 |
Why?
|
Immunoassay | 1 | 2008 | 750 | 0.060 |
Why?
|
Urban Health Services | 1 | 2005 | 179 | 0.060 |
Why?
|
Insurance, Physician Services | 1 | 2004 | 24 | 0.060 |
Why?
|
Homozygote | 1 | 2009 | 1788 | 0.060 |
Why?
|
Liver Cirrhosis | 1 | 2014 | 1838 | 0.060 |
Why?
|
Pregnancy | 5 | 2021 | 29002 | 0.060 |
Why?
|
Running | 1 | 1988 | 476 | 0.060 |
Why?
|
Infant, Newborn | 4 | 2017 | 25470 | 0.060 |
Why?
|
Fasting | 1 | 2009 | 1587 | 0.050 |
Why?
|
Chloroquine | 3 | 1996 | 280 | 0.050 |
Why?
|
Heterozygote | 1 | 2009 | 2798 | 0.050 |
Why?
|
Gene Frequency | 1 | 2009 | 3585 | 0.050 |
Why?
|
Rural Health Services | 1 | 2005 | 378 | 0.050 |
Why?
|
Oxygen | 2 | 1990 | 4158 | 0.050 |
Why?
|
Nutritional Status | 1 | 1988 | 1587 | 0.040 |
Why?
|
Partial Pressure | 2 | 1990 | 252 | 0.040 |
Why?
|
Capital Expenditures | 1 | 1999 | 29 | 0.040 |
Why?
|
Vitamins | 1 | 1988 | 1602 | 0.040 |
Why?
|
Adiposity | 1 | 2009 | 1801 | 0.040 |
Why?
|
Female | 15 | 2021 | 378853 | 0.040 |
Why?
|
Superoxide Dismutase | 2 | 1991 | 601 | 0.040 |
Why?
|
Preventive Health Services | 1 | 2003 | 576 | 0.040 |
Why?
|
Glycine | 2 | 1991 | 674 | 0.040 |
Why?
|
Thiobarbiturates | 1 | 1997 | 5 | 0.040 |
Why?
|
Malondialdehyde | 1 | 1997 | 105 | 0.040 |
Why?
|
Peroxidases | 1 | 1997 | 138 | 0.040 |
Why?
|
Sulfonic Acids | 1 | 1997 | 96 | 0.040 |
Why?
|
Spectrophotometry | 1 | 1997 | 313 | 0.040 |
Why?
|
Classification | 1 | 1997 | 128 | 0.040 |
Why?
|
Nutrition Disorders | 1 | 2017 | 210 | 0.030 |
Why?
|
Spectrophotometry, Ultraviolet | 1 | 1996 | 219 | 0.030 |
Why?
|
Developed Countries | 1 | 1999 | 433 | 0.030 |
Why?
|
Lipid Peroxidation | 1 | 1997 | 283 | 0.030 |
Why?
|
Free Radical Scavengers | 1 | 1997 | 218 | 0.030 |
Why?
|
Benzothiazoles | 1 | 1997 | 250 | 0.030 |
Why?
|
Erythrocyte Membrane | 1 | 1997 | 442 | 0.030 |
Why?
|
Adult | 8 | 2016 | 213394 | 0.030 |
Why?
|
Blood Glucose | 1 | 2009 | 6237 | 0.030 |
Why?
|
Genotype | 1 | 2009 | 12951 | 0.030 |
Why?
|
Insulin | 1 | 2009 | 6569 | 0.030 |
Why?
|
World Health Organization | 1 | 2000 | 1321 | 0.030 |
Why?
|
Hydrogen Peroxide | 1 | 1997 | 730 | 0.030 |
Why?
|
Adenosine Triphosphate | 2 | 1991 | 2022 | 0.030 |
Why?
|
Osmolar Concentration | 1 | 2013 | 683 | 0.030 |
Why?
|
Kinetics | 2 | 1991 | 6475 | 0.030 |
Why?
|
Vitamin E | 1 | 1997 | 870 | 0.030 |
Why?
|
Primary Prevention | 1 | 2000 | 1165 | 0.030 |
Why?
|
Hemolysis | 1 | 2014 | 420 | 0.030 |
Why?
|
Maternal Welfare | 1 | 2012 | 115 | 0.030 |
Why?
|
Patient Acceptance of Health Care | 1 | 2005 | 3021 | 0.030 |
Why?
|
Phenotype | 1 | 2009 | 16301 | 0.020 |
Why?
|
Oxidation-Reduction | 1 | 1997 | 2184 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2009 | 21694 | 0.020 |
Why?
|
Severity of Illness Index | 1 | 2009 | 15511 | 0.020 |
Why?
|
Nucleotidases | 1 | 1990 | 31 | 0.020 |
Why?
|
Purine Nucleotides | 1 | 1990 | 28 | 0.020 |
Why?
|
Catalase | 1 | 1991 | 223 | 0.020 |
Why?
|
Brain Diseases, Metabolic | 1 | 2010 | 41 | 0.020 |
Why?
|
Perinatal Care | 1 | 2012 | 225 | 0.020 |
Why?
|
Child | 6 | 2021 | 77033 | 0.020 |
Why?
|
Terminology as Topic | 1 | 1997 | 1548 | 0.020 |
Why?
|
Carbon Radioisotopes | 1 | 1991 | 596 | 0.020 |
Why?
|
Inosine Monophosphate | 1 | 1988 | 10 | 0.020 |
Why?
|
Child Welfare | 1 | 2012 | 520 | 0.020 |
Why?
|
Amino Acid Metabolism, Inborn Errors | 1 | 2010 | 255 | 0.020 |
Why?
|
Iron | 1 | 1996 | 1776 | 0.020 |
Why?
|
Income | 1 | 2016 | 1877 | 0.020 |
Why?
|
Adenosine Diphosphate | 1 | 1988 | 425 | 0.020 |
Why?
|
HIV Infections | 1 | 2013 | 16764 | 0.020 |
Why?
|
Drug Evaluation | 1 | 1988 | 637 | 0.020 |
Why?
|
ROC Curve | 1 | 2014 | 3526 | 0.020 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 1990 | 1580 | 0.020 |
Why?
|
Health Transition | 1 | 2005 | 34 | 0.020 |
Why?
|
Biological Transport | 1 | 1990 | 2118 | 0.020 |
Why?
|
Adenine | 1 | 1991 | 940 | 0.020 |
Why?
|
Poverty | 1 | 2017 | 2626 | 0.020 |
Why?
|
gamma-Glutamyltransferase | 1 | 1984 | 133 | 0.020 |
Why?
|
Poland | 1 | 2004 | 184 | 0.010 |
Why?
|
Hydrogen-Ion Concentration | 1 | 1988 | 2558 | 0.010 |
Why?
|
Nutritional Sciences | 1 | 1984 | 137 | 0.010 |
Why?
|
Rural Health | 1 | 1984 | 304 | 0.010 |
Why?
|
Biopsy | 1 | 2014 | 6722 | 0.010 |
Why?
|
Taxes | 1 | 2004 | 221 | 0.010 |
Why?
|
Alkaline Phosphatase | 1 | 1984 | 864 | 0.010 |
Why?
|
Vietnam | 1 | 2002 | 408 | 0.010 |
Why?
|
Risk | 1 | 2013 | 9684 | 0.010 |
Why?
|
Male | 7 | 2017 | 349022 | 0.010 |
Why?
|
Forecasting | 1 | 2010 | 2952 | 0.010 |
Why?
|
Efficiency, Organizational | 1 | 2005 | 694 | 0.010 |
Why?
|
Reference Values | 1 | 1988 | 4983 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2017 | 9812 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2021 | 24714 | 0.010 |
Why?
|
China | 1 | 2005 | 2225 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 1991 | 10945 | 0.010 |
Why?
|
Muscular Diseases | 1 | 1983 | 555 | 0.010 |
Why?
|
Insurance Coverage | 1 | 2010 | 1891 | 0.010 |
Why?
|
Fee-for-Service Plans | 1 | 2004 | 694 | 0.010 |
Why?
|
Liver | 1 | 2014 | 7449 | 0.010 |
Why?
|
Acetyltransferases | 1 | 1979 | 236 | 0.010 |
Why?
|
Prenatal Diagnosis | 1 | 1984 | 1227 | 0.010 |
Why?
|
Home Care Services | 1 | 2004 | 602 | 0.010 |
Why?
|
Spectroscopy, Mossbauer | 1 | 1996 | 2 | 0.010 |
Why?
|
Health Education | 1 | 1984 | 1054 | 0.010 |
Why?
|
Quinine | 1 | 1996 | 54 | 0.010 |
Why?
|
Hemeproteins | 1 | 1996 | 63 | 0.010 |
Why?
|
Cystic Fibrosis | 1 | 1984 | 1177 | 0.010 |
Why?
|
Cells, Cultured | 1 | 1991 | 19220 | 0.010 |
Why?
|
Models, Biological | 1 | 1990 | 9609 | 0.010 |
Why?
|
Social Class | 1 | 2002 | 1974 | 0.010 |
Why?
|
Animals | 4 | 1996 | 168368 | 0.010 |
Why?
|
Emergency Medical Services | 1 | 2004 | 1904 | 0.010 |
Why?
|
Incidence | 1 | 2010 | 20913 | 0.010 |
Why?
|
Research Design | 1 | 1988 | 5959 | 0.010 |
Why?
|
United States | 1 | 1999 | 69573 | 0.010 |
Why?
|
Diet | 1 | 1988 | 7876 | 0.010 |
Why?
|
Prospective Studies | 1 | 2014 | 53037 | 0.010 |
Why?
|
Malaria | 1 | 1996 | 1234 | 0.000 |
Why?
|
Time Factors | 1 | 1988 | 40050 | 0.000 |
Why?
|
Adolescent | 2 | 2005 | 85405 | 0.000 |
Why?
|
Retrospective Studies | 1 | 2014 | 76631 | 0.000 |
Why?
|
Myoglobinuria | 1 | 1983 | 23 | 0.000 |
Why?
|
Cathepsin D | 1 | 1983 | 61 | 0.000 |
Why?
|
Hyperbilirubinemia | 1 | 1983 | 73 | 0.000 |
Why?
|
Cathepsins | 1 | 1983 | 237 | 0.000 |
Why?
|
Amniotic Fluid | 1 | 1984 | 366 | 0.000 |
Why?
|
Creatine Kinase | 1 | 1983 | 694 | 0.000 |
Why?
|
Anti-Bacterial Agents | 1 | 1979 | 7136 | 0.000 |
Why?
|
Genetic Counseling | 1 | 1984 | 601 | 0.000 |
Why?
|
Amikacin | 1 | 1979 | 48 | 0.000 |
Why?
|
Middle Aged | 2 | 2005 | 212863 | 0.000 |
Why?
|
Tobramycin | 1 | 1979 | 69 | 0.000 |
Why?
|
Aminoglycosides | 1 | 1979 | 159 | 0.000 |
Why?
|
Gentamicins | 1 | 1979 | 253 | 0.000 |
Why?
|
Muscles | 1 | 1983 | 1608 | 0.000 |
Why?
|
Aged | 1 | 2002 | 162698 | 0.000 |
Why?
|
Rats | 1 | 1983 | 24270 | 0.000 |
Why?
|
Concepts
(240)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(8)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_